m+Medelevator.RU
← Поиск публикаций
Acta oto-laryngologica · 2026

Using the electronic baby bottle to support tongue-tie diagnosis in infants: a prospective study.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Siggard Lene Dahl, Rytter Dorte, Lildholdt Torben

Аннотация

BACKGROUND: Tongue-tie may interfere with infant feeding, but diagnosis remains challenging due to lack of objective criteria.

AIMS/OBJECTIVES: To evaluate the clinical utility of the electronic baby bottle (EBB), a novel device recording intraoral forces during suckling.

MATERIAL AND METHODS: A prospective cohort study across four ENT clinics included 106 infants under 3 months, assessed at baseline and 1-week follow-up. ENT specialists rated the EBB's diagnostic value; tongue anatomy and mobility were screened using the TABBY scoring system. Eighty-five infants underwent frenotomy; 21 not meeting diagnostic criteria served as controls.

RESULTS: The EBB received high diagnostic value scores in both groups, with no significant change following frenotomy. TABBY scores improved significantly post-operatively (mean difference 3.87 (95% CI 3.4-4.3), p < 0.001), consistent with expected anatomical changes. Infant cooperation was positively associated with device utility (p < 0.001). Frenotomy was associated with significant improvements in caregiver-reported symptoms, including latch quality, breast pain, and feeding duration.

CONCLUSIONS AND SIGNIFICANCE: ENT specialists rated the EBB as subjectively useful, but no signal-level change was detected following frenotomy using clinician-based rating. Subjective interpretation of EBB readouts is insufficient as a standalone diagnostic approach; automated signal analysis on biomechanical responsiveness is required to realise the device's diagnostic potential. Further prospective validation is needed before clinical adoption can be recommended.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты